Colorectal Cancer Clinical Trials in Massachusetts

Showing 161-180 of 269 trials

Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI

NCT02833753

This is a Phase I dose escalation study to determine how much chemotherapy can be safely administered into the abdomen while experiencing the fewest possible side effects.

Colorectal CancerAppendix CancerPeritoneal Carcinomatosis

University of Massachusetts, Worcester14 participantsStarted Jul 2016

Worcester, Massachusetts, United States

TERMINATEDPhase 226 miles

Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

NCT01507545

The purpose of this study is to evaluate whether therapy with MORAb-004 is effective and safe in the treatment of metastatic, colorectal cancer.

Metastatic Colorectal CancerColorectal Cancer

Morphotek154 participantsStarted Mar 2012

Alhambra, California, United States • Bakersfield, California, United States • Burbank, California, United States +64 more locations

Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI

Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

Colorectal Cancer Trials in Other Cities

The Genomic Medicine at VA Study

Nivolumab+Ipilimumab+RT in MSS mCRC

Predicting Disease Progression and/or Recurrence in Cancer

Dabrafenib + Trametinib + PDR001 In Colorectal Cancer

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

Preoperative Radiotherapy and E7046 in Rectum Cancer

Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study

BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Other Conditions in Massachusetts